A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor

被引：15
|
作者：
Leroy, L. [1 ]
Lafarge, X. [2 ]
Blouin, L. [2 ]
Bijou, F. [3 ]
Durrieu, F. [4 ]
Olivier, E. [5 ]
Le Moulec, S. [1 ]
机构：
[1] Bergonie Inst, Dept Med Oncol, Bordeaux, France
[2] EFS, INSERM, Unit 1035, Bordeaux, France
[3] Bergonie Inst, Dept Med Hematol, Bordeaux, France
[4] Bergonie Inst, Dept Biol Hematol, Bordeaux, France
[5] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 02期
关键词：
IPILIMUMAB-INDUCED THROMBOCYTOPENIA;
D O I：
10.1093/annonc/mdx693
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：514 / 515
页数：3
相关论文
共 50 条
  • [41] Fatal outcome of atezolizumab in a patient with immune-mediated pneumonitis, thrombocytopenia, and cardiac dysfunction: A case report
    Li, Jia
    Deng, Xubin
    Wang, Birong
    Li, Weidong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (12) : 607 - 611
  • [42] Immune Thrombocytopenia-A Neglected Adverse Event of PD-1 and PD-L1 Inhibitors in Clinical Trials Reply
    Wang, Yucai
    Yang, Fang
    Wang, Michael L.
    JAMA ONCOLOGY, 2019, 5 (11) : 1641 - +
  • [43] Immune-mediated liver injury induced by PD-1/PD-L1 checkpoint inhibitors is different from idiosyncratic drug-induced liver injury
    Wang, Yan
    Meng, Yao
    Zhang, Mengmeng
    Guo, Tiantian
    Chen, Wei
    Liu, Liwei
    Zhao, Xinyan
    JOURNAL OF HEPATOLOGY, 2024, 80 : S121 - S121
  • [44] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [45] Platelet antibodies and diagnosis of immune-mediated thrombocytopenia
    Kiefel, V
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 2001, 28 (04): : 209 - 217
  • [46] PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
    Huang, Changsheng
    Ren, Shengxiang
    Chen, Yaqi
    Liu, Anyi
    Wu, Qi
    Jiang, Tao
    Lv, Panjing
    Song, Da
    Hu, Fuqing
    Lan, Jingqing
    Sun, Li
    Zheng, Xue
    Luo, Xuelai
    Chu, Qian
    Jia, Keyi
    Li, Yan
    Wang, Jun
    Zou, Caicun
    Hu, Junbo
    Wang, Guihua
    SCIENCE ADVANCES, 2023, 9 (21)
  • [47] Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
    Sun, Zhenou
    Ma, Xuan
    Zhao, Chong
    Fan, Lihong
    Yin, Shutao
    Hu, Hongbo
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [48] OxaliplatinAcute immune-mediated thrombocytopenia: case report
    Reactions Weekly, 2014, 1505 (1) : 27 - 27
  • [49] IMMUNE-MEDIATED THROMBOCYTOPENIA ASSOCIATED WITH RANITIDINE THERAPY
    GIBSON, PR
    PIDCOCK, ME
    MEDICAL JOURNAL OF AUSTRALIA, 1986, 145 (11-12) : 661 - 662
  • [50] Immune-mediated thrombocytopenia associated with valley fever
    Yu, MK
    Rodgers, GM
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (01) : 81 - 82
12345